McLean Asset Management Corp

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1833140 TYSONS, VA

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$166,485

-$43,673 QoQ

Shares Held

267

-1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,059

of 1,322 holders

Holding Since

Dec 2020

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

McLean Asset Management Corp holds $166,485 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc. This page	267	$166,485

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$166,485	267	-1.8%	Shares	Sole	2026-08-12
2026-03-31	$210,158	272	+3.4%	Shares	Sole	2026-04-22
2024-09-30	$276,476	263	0.0%	Shares	Sole	2024-10-07
2024-06-30	$276,420	263	-27.3%	Shares	Sole	2024-07-12
2024-03-31	$348,421	362	+0.3%	Shares	Sole	2024-04-10
2023-12-31	$317,062	361	-0.8%	Shares	Sole	2024-01-08
2023-09-30	$299,557	364	0.0%	Shares	Sole	2023-10-12
2023-06-30	$261,548	364	-0.3%	Shares	Sole	2023-07-10
2023-03-31	$299,909	365	-1.1%	Shares	Sole	2023-04-11
2022-12-31	$266,229	369	+1.1%	Shares	Sole	2023-01-19
2022-09-30	$251,437	365	+2.5%	Shares	Sole	2022-10-12
2022-06-30	$210,442	356	-0.8%	Shares	Sole	2022-07-07
2022-03-31	$250,732	359	+2.6%	Shares	Sole	2022-04-08
2021-12-31	$221,032	350	-13.8%	Shares	Sole	2022-01-14
2021-09-30	$245,703	406	0.0%	Shares	Sole	2021-10-27
2021-06-30	$226,767	406	-1.9%	Shares	Sole	2021-07-19
2020-12-31	$200,007	414	—	Shares	Sole	2021-01-27
No filing history on record for this holder in this stock.